Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
9138studies shown
Showing 451-475 of 9,138
RecruitingNCT07186309

A Test for Postpartum Depression at Home

This study is recruiting in the United States. It is testing a Test for depression.

DepressionDeviceOver 18 Years
Countries
United States
Sponsor
University of Virginia
Condition
Depression
RecruitingNCT06254612

SP-624 for depression

This study is recruiting in the United States. It is testing SP-624 for depression.

DepressionOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
Sirtsei Pharmaceuticals, Inc.
Condition
Depression
Not Yet RecruitingNCT07161492

A Study on Functional Connectome and rTMS Intervention of Cognitive Flexibility Impairment in people with Major Depressive Disorder

This study is looking at whether Repetitive Transcranial Magnetic Stimulation can help people with major depression or Cognitive Impairment. Participants take part in Repetitive Transcranial Magnetic Stimulation and complete follow-up assessments.

DepressionDrugFrom 18 Years to 45 Years
Countries
China
Sponsor
Second Xiangya Hospital of Central South University
Condition
Depression
Not Yet RecruitingNCT06490120

A Study on Young Individuals' Mental Health in Sweden

This observational study is following people with Mental Health Issue, Depression, Anxiety, or Well-Being, Psychological to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.

DepressionOtherFrom 15 Years to 29 Years
Countries
Sweden
Sponsor
Uppsala University
Condition
Depression
RecruitingNCT06524830

VLS-01 Buccal Film, Compared to Placebo for depression

This study is recruiting in Australia, in Canada, in the United Kingdom, and in the United States. It is testing VLS-01 Buccal Film, Compared to Placebo for depression.

DepressionOtherFrom 18 Years to 65 Years
Countries
Australia, Canada, United Kingdom, United States
Sponsor
atai Therapeutics, Inc.
Condition
Depression
RecruitingNCT07300969

Effectiveness of DT-101 in depression

This study is recruiting in multiple countries, including in Bulgaria, in Czech Republic, and in Poland. It is testing DT-101 for depression.

DepressionOtherFrom 18 Years to 75 Years
Countries
Bulgaria, Czech Republic, Poland, United Kingdom, United States
Sponsor
Draig Therapeutics Ltd
Condition
Depression
RecruitingNCT07227454

Esketamine for depression

This study is recruiting in Brazil, in Taiwan, and in the United States. It is testing esketamine for depression.

DepressionOtherFrom 12 Years to 17 Years
Countries
Brazil, Taiwan, United States
Sponsor
Janssen Research & Development, LLC
Condition
Depression
RecruitingNCT07065240

SPT-300 (GlyphAllo) for depression

This study is recruiting in multiple countries, including in Bulgaria, in Czech Republic, and in Germany. It is testing SPT-300 (GlyphAllo) for depression.

DepressionOtherFrom 18 Years to 65 Years
Countries
Bulgaria, Czech Republic, Germany, Poland, Slovakia, United States
Sponsor
Seaport Therapeutics
Condition
Depression
RecruitingNCT07196501

Maintenance Effect of NBI-1065845 for depression

This study is recruiting in multiple countries, including in Australia, in Bulgaria, and in Canada. It is testing Maintenance Effect of NBI-1065845 for depression.

DepressionOtherOver 18 Years
Countries
Australia, Bulgaria, Canada, Estonia, Italy, Poland, Serbia, South Korea, Spain, Taiwan, United States
Sponsor
Neurocrine Biosciences
Condition
Depression
RecruitingNCT06958692

A study of Dextromethorphan and Bupropion Sustained-Release Tablets in people with Major Depressive Disorder

This study is comparing Dextromethorphan and Bupropion Sustained-Release Tablets with placebo for people with depression. Participants receive Dextromethorphan and Bupropion Sustained-Release Tablets or placebo and complete study visits and assessments.

DepressionDrugFrom 18 Years to 65 Years
Countries
China
Sponsor
CSPC Ouyi Pharmaceutical Co., Ltd.
Condition
Depression
Mental Health | Clinical Trials | HopeStage Research